VECTORMUNE ND

Dosage

Children: Refer to specific medications used to treat the particular disease for dosing information.

Adults: Refer to specific medications used to treat the particular disease for dosing information.

Mechanism of action

The mechanism of action varies significantly depending on the specific disease in question. For infectious diseases, pathogens may interact with host cells, leading to inflammation, immune response activation, or tissue damage. Chronic diseases often involve complex interactions between genetic factors, lifestyle choices, and environmental influences. For example, in autoimmune diseases, the immune system mistakenly targets healthy cells, leading to inflammation and tissue destruction.

Pharmacodynamics

Pharmacodynamics of disease involves understanding how the disease state affects physiological functions and the body's response to treatment. In infectious diseases, the presence of pathogens can lead to altered immune responses, while chronic diseases may involve changes in metabolic pathways, hormonal balances, or cellular functions. Medications targeting disease processes aim to restore normal function, alleviate symptoms, or eradicate pathogens.

Pharmacokinetics

Pharmacokinetics is not applicable to the term 'disease' as it refers to the movement of drugs within the body, including absorption, distribution, metabolism, and excretion of specific medications used to treat diseases. Each medication will have its own pharmacokinetic profile depending on its chemical properties and the disease being treated.

Indications

• Clinical term 1
• Common term 1
• Clinical term 2
• Common term 2

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing guidelines.

Adults: Refer to the BNF for specific adult dosing guidelines.

Mechanism of action

Dose acts by modulating the activity of specific neurotransmitter receptors and ion channels, influencing various physiological pathways. Its precise mechanism may involve interactions with G-protein coupled receptors, leading to downstream signaling effects that impact cellular responses.

Pharmacodynamics

Dose exhibits a range of effects depending on the dosage and target tissues. It is known to alter neurotransmitter release, affect ion conductance, and influence metabolic pathways, thereby contributing to its therapeutic efficacy and potential side effects.

Pharmacokinetics

Dose is generally absorbed following administration, with peak plasma concentrations occurring within a specified timeframe. Its distribution is influenced by tissue binding and permeability across cell membranes. The drug is metabolized primarily in the liver, with metabolites being excreted via renal and biliary routes. The half-life can vary based on individual patient factors, including age, liver function, and other concurrent medications.

Indications

• Cystic fibrosis
• Duchenne muscular dystrophy
• Hemophilia
• Certain cancers (e.g., melanoma)
• Inherited retinal diseases
• Sickle cell disease

Dosage

Children: Dosage for paediatric patients is also highly variable and must be determined based on the specific gene therapy product and the child's condition. Consult product-specific guidelines for appropriate dosing.

Adults: Dosage is highly variable and depends on the specific gene therapy product used, the condition being treated, and individual patient factors. Refer to specific product guidelines for dosing information.

Mechanism of action

Gene therapy primarily works by delivering therapeutic genes into a patient's cells using vectors, often derived from viruses. These vectors can integrate into the host genome or exist as episomes to produce the desired protein, potentially correcting the underlying genetic defect. The successful expression of the therapeutic gene can restore normal function or inhibit disease progression.

Pharmacodynamics

The pharmacodynamics of gene therapy depend on the type of gene delivered and the disease being treated. When a functional gene is introduced, it can lead to the production of proteins that may reverse or mitigate the effects of the disease. This can result in improved cellular function, restoration of metabolic pathways, or enhanced immune responses, depending on the target condition.

Pharmacokinetics

Pharmacokinetics of gene therapy can vary greatly based on the delivery method and the specific gene being targeted. Following administration, the vector must reach the target cells, which may involve overcoming cellular barriers. Once inside, the gene can be expressed, but the duration and efficiency of expression can vary. Some genes may integrate into the host genome, providing long-term effects, while others may be transient.

Pregnancy

The safety of gene therapy during pregnancy is not well established. Caution is advised and potential benefits should be weighed against risks.

Breast-feeding

It is unclear whether gene therapy affects breast milk or nursing infants. Caution is advised.

Storage

Gene therapies should be stored according to the manufacturer's specifications, typically in a cool, dry place, and protected from light.

Indications

• Herpes Simplex Virus infection
• Genital herpes
• Cold sores
• Varicella (chickenpox)
• Herpes Zoster (shingles)
• Prevention of herpes virus reactivation in immunocompromised patients

Dosage

Adults: Refer to the BNF for specific dosing recommendations for adults

Mechanism of action

Herpesvirus antiviral medications, such as acyclovir and valacyclovir, primarily inhibit viral DNA synthesis. They are nucleoside analogs that get incorporated into the growing viral DNA chain, leading to premature termination of DNA synthesis. This action is selective for infected cells, as the drugs are activated by viral thymidine kinase, which is present in infected cells but absent in uninfected cells.

Pharmacodynamics

The pharmacodynamic profile of herpesvirus antivirals shows that they are more effective when administered early in the course of the infection. Acyclovir exhibits a higher affinity for viral DNA polymerase than for the host cell's enzymes, which reduces toxicity to human cells. The efficacy of these medications is related to the degree of viral replication; higher viral loads may require higher doses or more frequent administration.

Pharmacokinetics

Acyclovir is well absorbed after oral administration, with a bioavailability of approximately 15-30%. It is widely distributed in body fluids and tissues, including the central nervous system. It undergoes renal excretion, primarily as unchanged drug, necessitating dosage adjustment in patients with renal impairment. The half-life of acyclovir ranges from 2.5 to 3 hours in healthy adults, but this can be prolonged in cases of renal dysfunction. Valacyclovir, a prodrug of acyclovir, has improved bioavailability of approximately 54% and is converted to acyclovir in the body.

Contra-indications

• Hypersensitivity to acyclovir or any of its components
• Severe renal impairment

Adverse effects

• Nausea
• Diarrhea
• Headache
• Dizziness
• Rash
• Renal toxicity
• Neurotoxicity (in cases of rapid infusion or dehydration)

Interactions

• Probenecid may reduce renal clearance of acyclovir
• Other nephrotoxic agents may increase the risk of renal impairment
• Zidovudine may increase the risk of hematological toxicity

Precautions

• Monitor renal function during treatment, especially in patients with pre-existing renal disease
• Hydration is important to prevent crystallization in the kidneys
• Use caution in patients with neurological conditions

Pregnancy

Acyclovir is classified as a category B drug. Animal studies have not demonstrated a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.

Breast-feeding

Acyclovir is excreted in breast milk in small amounts. Caution is advised when administering to nursing mothers.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

• Oral tablets
• Topical cream
• Intravenous injection
• Oral suspension

Dosage

Children: Refer to specific drug guidelines or consult the BNF for Children for appropriate dosing information.

Adults: Refer to specific drug guidelines or consult the BNF for appropriate dosing information.

Indications

• Measles
• Mumps
• Rubella
• Varicella (chickenpox)
• Yellow fever
• Rotavirus
• Intranasal influenza

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and vaccine type.

Adults: Refer to specific product guidelines for dosing information, as it can vary by vaccine type and brand.

Mechanism of action

Live vaccines work by introducing a weakened or attenuated form of a pathogen into the body. This stimulates the immune system to recognize and respond to the pathogen, leading to the production of antibodies and memory cells that provide long-term protection against future infections by the same pathogen.

Pharmacodynamics

The pharmacodynamics of live vaccines involve the activation of both humoral and cellular immunity. Following vaccination, the immune system generates a robust response, including the production of specific antibodies and the activation of T cells that can recognize and eliminate infected cells. This dual action helps establish long-term immunity.

Pharmacokinetics

The pharmacokinetics of live vaccines vary depending on the specific vaccine. Generally, the vaccine is administered via injection, allowing the live attenuated organisms to enter the bloodstream. The immune response typically begins within days and can last for years, depending on the vaccine. Live vaccines are usually stored under refrigeration to maintain their viability, and they should be administered within their expiration dates.

Interactions

• livevaccines + abrocitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + baricitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + filgotinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + dexrazoxane: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + iron chelators: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ponesimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + upadacitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + diroximelfumarate: Moderate (increases risk of generalised infection (possibly life-threatening))

Indications

• Prevention of Newcastle disease in poultry
• Potential oncolytic therapy in cancer treatment

Dosage

Children: Refer to specific treatment protocols or clinical guidelines for dosages, as they may vary based on the context of use.

Adults: Refer to specific treatment protocols or clinical guidelines for dosages, as they may vary based on the context of use.

Mechanism of action

Newcastle disease virus exerts its effects primarily through the induction of apoptosis in infected cells and the activation of the host immune system. The virus binds to specific receptors on the surface of host cells, facilitating viral entry and replication. It leads to the release of pro-inflammatory cytokines and enhances the anti-tumor immune response in the context of oncolytic therapies.

Pharmacodynamics

The pharmacodynamics of Newcastle disease virus involves its ability to replicate in tumor cells, leading to cell lysis and release of viral progeny that can further infect and destroy adjacent tumor cells. The host's immune system is subsequently activated, enhancing the overall anti-tumor response.

Pharmacokinetics

The pharmacokinetics of Newcastle disease virus is complex, as it involves viral replication and dissemination within the host. Following administration, the virus replicates at the site of infection, with peak viral loads observed at various time points depending on the route of administration and the host's immune status. The virus is typically cleared by the immune system over time, although its persistence can vary based on the type of host cells infected.

Pregnancy

Safety in pregnancy has not been established. Use with caution and only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Safety during breastfeeding is not well established. Caution is advised.

Storage

Store in a cool, dry place away from direct sunlight and heat. Follow specific storage requirements if available.

Indications

• High-quality protein source
• Nutritional support for muscle maintenance
• Source of B vitamins
• Source of selenium
• Source of zinc

Dosage

Children: Protein needs for children vary by age. It is recommended to consult specific dietary guidelines for children, which suggest that the intake of protein should be proportionate to their age, weight, and level of physical activity.

Adults: The recommended dietary allowance for protein varies, but generally, adults require approximately 46-56 grams of protein per day, which can be met through the consumption of turkey as part of a balanced diet.

Mechanism of action

Turkey meat contains proteins that are broken down into amino acids during digestion, which the body utilizes for various physiological functions, including muscle repair, hormone production, and immune function. The presence of tryptophan, an amino acid found in turkey, is known to affect serotonin levels in the brain, which may influence mood and sleep patterns.

Pharmacodynamics

Turkey is rich in amino acids, vitamins, and minerals, which can support overall health. The bioavailability of nutrients such as zinc and B vitamins from turkey contributes to various metabolic processes and functions, including energy production, immune response, and nervous system health. The consumption of turkey is associated with satiety and may impact dietary patterns due to its protein content.

Pharmacokinetics

Nutrient absorption from turkey occurs primarily in the gastrointestinal tract, where proteins are digested into amino acids, and vitamins and minerals are absorbed into the bloodstream. The rate of absorption may vary based on the method of cooking and individual digestive health. Protein metabolism involves hepatic processing, where amino acids are utilized or stored as needed by the body.

Pregnancy

Generally considered safe to consume during pregnancy, but should be cooked thoroughly to avoid foodborne illnesses.

Breast-feeding

Typically safe for breastfeeding mothers, but should be prepared properly to ensure safety for both mother and infant.

Storage

Store in a cool, dry place. Fresh turkey should be refrigerated and consumed within a few days or frozen for longer storage.

Indications

• Gene therapy for genetic disorders
• Cancer treatment
• Vaccination against infectious diseases
• Treatment of certain viral infections

Dosage

Children: Dosage varies based on the specific vector and therapeutic application. Refer to specific guidelines or clinical studies for detailed dosing information.

Adults: Dosage varies widely based on the specific vector and therapeutic application. Refer to specific guidelines or clinical studies for detailed dosing information.

Mechanism of action

Vectors, particularly viral vectors, operate by utilizing the natural ability of viruses to infect host cells. They are engineered to carry therapeutic genes into target cells. Once inside the cell, the therapeutic gene can be expressed, leading to the production of a desired protein that can correct a deficiency or inhibit disease progression.

Pharmacodynamics

The pharmacodynamics of vectors depends on the type and design of the vector used. In gene therapy, the effectiveness of a vector is influenced by its ability to target specific cells, the efficiency of gene delivery, and the subsequent expression of the therapeutic gene. These factors can result in altered biological responses, which may include the restoration of normal function in diseased cells or modulation of immune responses in the case of vaccines.

Pharmacokinetics

The pharmacokinetics of vectors involves their distribution, metabolism, and elimination from the body. After administration, vectors must reach target cells to exert their effects. The half-life of vectors can vary significantly based on their type, such as adenoviral, lentiviral, or plasmid vectors. Factors influencing pharmacokinetics include the route of administration, vector stability, and the host immune response, which can lead to rapid clearance of the vector.

Pregnancy

Safety during pregnancy has not been established; caution is advised.

Breast-feeding

Caution is advised as the effects on a nursing infant are unknown.

Storage

Store at room temperature, away from moisture and heat.

Indications

• Influenza
• HIV/AIDS
• Hepatitis B and C
• Herpes simplex virus infections
• Cytomegalovirus infections
• COVID-19
• Respiratory syncytial virus infections

Dosage

Children: Refer to specific antiviral agents for dosing guidance.

Adults: Refer to specific antiviral agents for dosing guidance.

Mechanism of action

Viruses infect host cells by attaching to specific receptors on the cell surface. Once inside, they hijack the host cell's machinery to replicate their genetic material and produce viral proteins. New viral particles are assembled and released from the host cell, often destroying the cell in the process. The specific mechanism can vary depending on the virus type, including integration into the host genome in retroviruses or utilizing specific pathways for replication.

Pharmacodynamics

The pharmacodynamics of antiviral agents depend on the specific virus and the mechanism of action. Antiviral drugs may inhibit viral entry into host cells, block viral replication, or prevent the assembly of new virions. The effectiveness of antiviral therapy often relates to the stage of viral replication and the immune response of the host.

Pharmacokinetics

Pharmacokinetics of antiviral drugs varies widely based on the specific medication used. Generally, antiviral agents are absorbed through the gastrointestinal tract and distributed throughout the body. They may undergo hepatic metabolism and are often excreted through the kidneys. The half-life of these drugs can range from a few hours to several days, influencing dosing schedules.